Our findings suggest that patients who use insulin are at increased risk of sepsis, which may be primarily explained by the fact that insulin therapy typically indicates more severe or advanced cases of T2DM [31], placing these patients at inherently higher risk of infections and sepsis. The gene discussed is INS; the disease is infection.